Cargando…
Type II Secretory Phospholipase A(2) and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study
BACKGROUND: Serum type II secretory phospholipase A(2) (sPLA(2)-IIa) has been found to be predictive of adverse outcomes in patients with stable coronary heart disease. Compounds targeting sPLA(2)-IIa are already under development. This study investigated if an association of sPLA(2)-IIa with second...
Autores principales: | Breitling, Lutz P., Koenig, Wolfgang, Fischer, Marcus, Mallat, Ziad, Hengstenberg, Christian, Rothenbacher, Dietrich, Brenner, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142130/ https://www.ncbi.nlm.nih.gov/pubmed/21799821 http://dx.doi.org/10.1371/journal.pone.0022318 |
Ejemplares similares
-
Relationship between Inflammatory Cytokines and Uric Acid Levels with Adverse Cardiovascular Outcomes in Patients with Stable Coronary Heart Disease
por: Rothenbacher, Dietrich, et al.
Publicado: (2012) -
Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care
por: Rothenbacher, Dietrich, et al.
Publicado: (2013) -
Secretory Phospholipase A(2)-IIA and Cardiovascular Disease: A Mendelian Randomization Study
por: Holmes, Michael V., et al.
Publicado: (2013) -
Prognostic value of long-term trajectories of depression for incident diabetes mellitus in patients with stable coronary heart disease
por: Peter, Raphael S., et al.
Publicado: (2021) -
Smoking and γ-Glutamyltransferase: Opposite Interactions with Alcohol Consumption and Body Mass Index
por: Breitling, Lutz P., et al.
Publicado: (2010)